Study on Luspatercept and Epoetin Alfa for Patients with Low-Risk Myelodysplastic Syndrome Without Ring Sideroblasts Who Did Not Respond to ESA
- Substances:Epoetin AlfaLuspatercept
France- Participants:18–64 years · 65+ years
- Substances:Epoetin Alfa
Rare diseases
Investigational molecules
Locations
FranceStudy on the Safety and Effectiveness of GSK4532990 for Adults Aged 18-65 with Alcohol-Related Liver Disease
FranceStudy on Long-Term Safety and Effects of Iptacopan for Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
FranceStudy on Durvalumab and Tremelimumab for Liver Cancer Patients Undergoing Electroporation Ablation
FranceStudy on HPV Vaccine After Treatment for High-Grade Cervical Lesions in Women Over 45
FranceStudy on Reducing Cutibacterium acnes in Shoulder Surgery for Men Using Benzoyl Peroxide and Ethanol-Povidone Iodine Combination
FranceStudy Comparing Itraconazole and Nebulised Amphotericin B with Itraconazole Alone for Patients with Chronic Pulmonary Aspergillosis
FranceStudy on Landiolol Hydrochloride and Sodium Chloride for Reducing Mortality in Patients with Septic Shock and High Heart Rate
FranceStudy on Hydroxychloroquine for Patients with Cutaneous Mastocytosis or Indolent Systemic Mastocytosis with Skin Involvement
FranceStudy of petosemtamab alone or with drug combination for patients with advanced colorectal cancer and other solid tumors
FranceStudy of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy
FranceStudy on Long-Term Safety of BI 907828 for Patients with Solid Tumors Who Previously Participated in a Study with This Medicine
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.